Eli Lilly has appointed Ilya Yuffa as executive vice president and president, Lilly Global Markets, effective January 1, 2027. This change comes as the company combines its US and international businesses into Lilly Global Markets.
The company expects this consolidation to accelerate decision-making, increase scalability, and provide a unified capability to improve human health through expanded access to medicines worldwide.
This announcement follows the news that Patrik Jonsson, executive vice president and president, Lilly International, will retire at the end of 2026 after a 36-year career at Lilly.
David A. Ricks, Lilly chair and CEO, stated that now is the right time to consolidate the company’s geographies for greater impact. He noted that Ilya Yuffa has run both the international and US businesses and is uniquely qualified to lead the company’s customer-facing operations worldwide.
Read Also: AstraZeneca Daiichi Sankyo start combo breast cancer trial
Yuffa joined Lilly in 1996 as a financial analyst and has held various leadership roles, including president and general manager of Lilly’s Italy Hub and president of Lilly Bio-Medicines.
Retiring president Jonsson began his career with the company in 1990 as a sales representative in Sweden. He went on to lead Lilly in several countries and held multiple executive roles, including president of Lilly Bio-Medicines and Lilly Immunology.
Ricks thanked Jonsson for his service to the company, acknowledging his dedication to improving lives by bringing medicines to people around the world.
The retirement of Jonsson marks the end of an era at Lilly. He has had a long and distinguished career with the company, and his dedication to improving lives will be remembered.
